Results 181 to 190 of about 26,813 (237)

Ivermectin Toxicity in Humans and Animals: Clinical Spectrum, Mechanisms, and Management. [PDF]

J Appl Toxicol
Yilmaz S, Göktaş B, Ateş İ, Çelik M.   +3 more
europepmc   +1 more source

Role of p38 MAPK in the cytokine reprogramming of a human leukemic cell line with a drug-resistant phenotype. [PDF]

Cell Commun Signal
Cadenas-Garrido P, García-Serna AM, Parrado A, Martínez-García J, Herrera-Suarez M, Cánovas M, de Diego Puente T, Saceda M, Pelegrin P, Díaz-Carrasco MS, Martín-Orozco E.   +10 more
europepmc   +1 more source

The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model. [PDF]

Sci Rep
Frayde-Gómez H, Chimal-Vega B, Pulido-Capiz A, Muñoz-Ayala A, Galindo-Hernández O, Vique-Sanchez JL, Leija-Montoya AG, Díaz-Molina R, Madero-Ayala PA, Ramos-Ibarra MA, García-González V.   +10 more
europepmc   +1 more source

The study on the transport and phosphorylation kinetics of zidovudine in the Chinese population and its significance for individualized antiretroviral therapy. [PDF]

Sci Rep
Tang F, Ji S, Lai X, Yan T, Peng J.
europepmc   +1 more source

Enhanced antitumor activity of atorvastatin and luteolin, with or without doxorubicin, in a solid Ehrlich carcinoma mouse model: modulation of ABC transporters, telomerase, and cancer stem cells. [PDF]

Med Oncol
Al-Ashmawy GM, El-Ashmawy NE, Hamada OB, Khedr NF.   +3 more
europepmc   +1 more source

PHLDA1 silencing in IMR-32 human neuroblastoma cells results in ABCB1 overexpression, augments chemoresistance and leads to increased growth of tumors. [PDF]

Sci Rep
Kudrycka M, Horwacik I, Brożyna AA, Żywicka M, Durbas M, Rokita H.   +5 more
europepmc   +1 more source

Challenges and prospects of <i>CYP2C19</i> genotype-guided clopidogrel therapy from the perspective of precision medicine. [PDF]

Front Pharmacol
Wang Z, Fu X, Zhang G.
europepmc   +1 more source

TLR2 activation potentiates P-glycoprotein-mediated methotrexate efflux and enhances cytotoxicity of human NK cells against acute lymphoblastic leukemia. [PDF]

Front Immunol
Álvarez-Carrasco P, Basurto-Olvera P, Jiménez-Hernández E, Medina-Sanson A, Maldonado-Bernal C.   +4 more
europepmc   +1 more source

KSQ-4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1-Mediated Multidrug Resistant Cancers. [PDF]

MedComm (2020)
Yang Q, Luo K, To KKW, Pan C, Fu K, Zhu S, Li S, Wang F, Wu C, Fu L.   +9 more
europepmc   +1 more source

Pharmacogenetics of CYP3A5 in Pediatric Patients With Eosinophilic Esophagitis. [PDF]

Clin Transl Sci
Noel-MacDonnell J, Almahbub N, Boone E, Wang W, Cheranova D, Harvey L, Shakhnovich V, Chevalier R.   +7 more
europepmc   +1 more source